An often under-recognized late manifestation of prostate adenocarcinoma (PCa) is the development of treatment-related neuroendocrine prostate cancer (NEPC). The aim of this study is to identify the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback